Divi's Laboratories company profile

DIVISLAB · NSE · INR

Compare Divi's Laboratories
₹11,180.50Change from previous close: +0.02%Absolute change: +₹2.50

Close · November 20, 2026

Company profile

Divi's Laboratories has 11,565 employees and is headquartered in Hyderabad, India.

Clients in North America, Europe, Asia and India, along with other international buyers, make up the markets Divi's Laboratories serves. The company manufactures and sells generic active pharmaceutical ingredients, chemical intermediates and nutraceuticals, and it also provides custom synthesis and contract manufacturing for APIs and intermediates. Its carotenoid line includes astaxanthin, beta-carotene and lycopene, alongside vitamins supplied to producers of food, supplements and animal feed. It also exports its products.

In the fiscal year ended March 2026, Divi's Laboratories reported revenue of INR 105.6 billion, up 12.8% from the previous year, and a net profit of INR 25.7 billion. The company employed 11,565 people. Incorporated in 1990 as Divi's Research Center, it changed its name to Divi's Laboratories Limited in 1994 and is headquartered in Hyderabad, India. Its shares are also listed on the BSE.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
India
Headquarters
Divi Towers, 500032, Hyderabad
Employees
11,565
Chief executive
Kiran Divi
Founded
1990
Fiscal year
April - March
Listing
DIVISLAB · NSE
Currency
INR
ISIN
INE361B01024

Divi's Laboratories and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Divi's LaboratoriesDIVISLABIndia$32.03B11,56534.0%88.2
Hansoh Pharmaceutical Group3692Hong Kong SAR China$23.77B9,64337.3%25.0
Jiangsu Hengrui Pharmaceuticals600276China$46.71B20,60227.4%35.1
Sun Pharmaceutical IndustriesSUNPHARMAIndia$48.8B47,00023.3%41.2
Torrent PharmaceuticalsTORNTPHARMIndia$19.25B18,25822.2%79.2
Shionogi4507Japan$16.75B6,22331.6%11.2

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Divi's Laboratories with its competitors